Overview Financials News + Filings Key Docs Holdings Ownership Insiders
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1.1 | 0.6 | 1.1 | 2.2 | 3.4 | 6.1 | 0.5 | 1.0 |
| Revenue growth | 71.5% | -40.5% | -52.2% | -33.8% | -44.6% | 1005.5% | -42.6% | |
| Cost of goods sold | 11.3 | 10.8 | 9.2 | 7.9 | 4.5 | 5.2 | 3.7 | 3.8 |
| Gross profit | -10.2 | -10.1 | -8.1 | -5.7 | -1.2 | 0.9 | -3.1 | -2.8 |
| Gross margin | -942.1% | -1606.8% | -764.1% | -255.9% | -34.4% | 14.3% | -569.9% | -293.0% |
| Selling, general and administrative | 56.1 | 38.3 | | | | | | |
| Research and development | 15.5 | 19.6 | 14.9 | 26.3 | 38.5 | 20.9 | 10.0 | 14.1 |
| General and administrative | | | 20.7 | 14.1 | 20.5 | 12.0 | 11.8 | 6.8 |
| EBITA | -81.8 | -68.0 | -43.6 | -46.0 | -60.1 | -37.3 | -24.8 | -23.7 |
| EBITA margin | -7557.1% | -10771.0% | -4110.9% | -2073.2% | -1790.4% | -615.4% | -4522.6% | -2481.2% |
| Amortization of intangibles | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | | 0.1 | 0.1 |
| EBIT | -81.8 | -68.0 | -43.6 | -46.1 | -60.1 | -37.3 | -24.9 | -23.8 |
| EBIT margin | -7561.9% | -10781.6% | -4110.9% | -2076.0% | -1792.3% | -615.4% | -4534.7% | -2487.9% |
| Pre-tax income | -113.3 | -69.8 | -46.2 | -54.8 | -63.6 | -39.4 | -25.0 | -26.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | -1.8 | -0.1 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% | 7.1% | 0.5% |
| Net income | -113.3 | -69.8 | -46.2 | -54.8 | -63.6 | -39.0 | -23.2 | -26.2 |
| Net margin | -10471.6% | -11054.4% | -4357.2% | -2467.9% | -1895.7% | -643.7% | -4234.5% | -2742.7% |
| |
| Diluted EPS | ($0.44) | ($0.27) | ($0.21) | ($0.46) | ($0.97) | ($0.88) | ($0.77) | ($2.07) |
| Shares outstanding (diluted) | 258.3 | 254.9 | 218.3 | 119.4 | 65.6 | 44.2 | 30.0 | 12.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|